Group 1 - The "zero tariff" policy for medical devices and drugs in Hainan is enhancing the competitiveness and attractiveness of the Boao Lecheng International Medical Tourism Pilot Zone by allowing hospitals to import foreign drugs and devices that are not yet available in China while reducing operational costs for hospitals and patients [1] - Since the implementation of the "zero tariff" policy on December 25, 2024, the Haikou Customs has supervised a total declared value of 60.239 million yuan for "zero tariff" medical devices and drugs, resulting in a tax exemption of 8.187 million yuan [1] - The Lecheng International Medical Tourism Pilot Zone is becoming a major channel for international innovative medical devices and drugs to enter China, supported by policies for licensed medical practices, research, and international medical exchanges [1] Group 2 - Hainan's efforts to attract international innovative medical device and drug companies reflect a broader initiative to promote high-quality development in the pharmaceutical industry through regulatory reforms and increased openness [2] - The Hainan Provincial Drug Administration has proposed five measures to enhance regulatory innovation, including creating a high ground for real-world research applications and facilitating product imports [2] - Over the next three years, Hainan aims to accelerate the application of real-world research, expand local production of innovative medical devices and drugs, and enhance international collaboration in medical technology projects [2] Group 3 - The "Lecheng research and application + Haikou production" model has enabled the successful import and local production of the drug "Kexaira" by First Voice Pharmaceutical, which was approved for full market entry in China through the real-world research green channel [3] - The Haikou National High-tech Zone is becoming a core area for Hainan's biopharmaceutical industry, with the pharmaceutical industry expected to account for nearly 80% of the province's total output value in 2024 [3] - The establishment of the Lecheng Medical Engineering Transformation Platform by the end of this year will serve as Hainan's first technology transfer and incubation platform in the field of innovative medical devices and drugs, promoting the transformation and incubation of innovative products [3]
（经济观察）海南自贸港扩大开放促医药产业发展